Eledon Pharmaceuticals, Inc.ELDNNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -50.87% |
| Q2 2025 | -78.15% |
| Q1 2025 | 88.77% |
| Q4 2024 | -171.43% |
| Q3 2024 | 199.06% |
| Q2 2024 | -34.18% |
| Q1 2024 | 77.75% |
| Q4 2023 | -914.29% |
| Q3 2023 | 12.50% |
| Q2 2023 | 45.21% |
| Q1 2023 | 82.66% |
| Q4 2022 | -476.71% |
| Q3 2022 | -12.31% |
| Q2 2022 | 5.80% |
| Q1 2022 | -11.29% |
| Q4 2021 | 6.06% |
| Q3 2021 | -32.00% |
| Q2 2021 | 12.28% |
| Q1 2021 | 93.04% |
| Q4 2020 | -48.64% |
| Q3 2020 | -101.09% |
| Q2 2020 | 67.84% |
| Q1 2020 | -48.17% |
| Q4 2019 | -43.39% |
| Q3 2019 | 36.04% |
| Q2 2019 | 32.73% |
| Q1 2019 | -6.64% |
| Q4 2018 | -30.84% |
| Q3 2018 | -9.51% |
| Q2 2018 | 6.44% |
| Q1 2018 | -19.20% |
| Q4 2017 | 28.96% |
| Q3 2017 | 73.32% |
| Q2 2017 | 82.85% |
| Q1 2017 | -529.17% |
| Q4 2016 | 98.70% |
| Q3 2016 | 34.39% |
| Q2 2016 | -3722.76% |
| Q1 2016 | -3.32% |
| Q4 2015 | 7.05% |